We are international
Donate
TEXT SIZE   


Dr. Richardson - Phase II Trial of Lenalidomide, Bortezomib, and Dexamethasone In Patients (pts) with Relapsed and Relapsed/Refractory Multiple Myeloma (MM): Updated Efficacy and Safety Data After >2 Years of Follow-up
Paul G. Richardson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
USA
12.02.10


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles